Olmesartan medoxomil 98%

Since our inception in 2016, We are into manufacturing of bulk drug Intermediates and served our customers with great quality products. From 2018 onwards, we ventured into Active Pharmaceutical Ingredients (API) manufacturing. Our core competence is to cater to ever changing and evolving requirements of our quality conscious clients who are looking for manufacturers committed to quality along with timely delivery and competitive prices. We have recently developed many basic and advanced intermediates and APIs at our in-house R & D centre to cater to existing and new customers.

Our commitment to quality and customer delight has been a key strength contributing to our growth and success. Our research and development division constantly strives to improve existing processes (within the regulatory framework) for cost reduction, develop new intermediates and perform custom synthesis as per customer’s requirements.

The same helped us in building and maintaining a clientele comprising many prominent pharmaceutical companies including MICRO LABS LTD, LAURUS LABS, DESANO, Cipla, and many other domestic and multinational customers.